Microbot Medical Closes $1.5M Private Placement

TL;DR

Microbot Medical raised $1.5M via private placement at $1.50/share. Funds for ops.

AI Summary

Microbot Medical Inc. announced on June 3, 2024, the closing of a private placement of approximately $1.5 million in gross proceeds. The company issued 1,000,000 shares of common stock at a purchase price of $1.50 per share. This offering was conducted without a prospectus and is subject to certain conditions.

Why It Matters

This capital infusion provides Microbot Medical with additional funds to support its operations and potential growth initiatives, which could impact its ability to develop and commercialize its medical devices.

Risk Assessment

Risk Level: medium — Private placements can be subject to market volatility and may not always be indicative of future stock performance, and the unregistered nature of the sale requires careful consideration.

Key Numbers

• $1.5M — Gross Proceeds (Funds raised in the private placement)
• 1,000,000 — Shares Issued (Number of common shares sold in the private placement)
• $1.50 — Price Per Share (The price at which shares were sold)

Key Players & Entities

• Microbot Medical Inc. (company) — Registrant
• $1.5 million (dollar_amount) — Gross proceeds from private placement
• June 3, 2024 (date) — Date of the private placement closing
• 1,000,000 shares (dollar_amount) — Number of shares issued
• $1.50 (dollar_amount) — Purchase price per share

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
• $1.50 — Common Stock"), at an offering price of $1.50 per share, for aggregate gross proceeds
• $2.35 million — ngs (as defined below) of approximately $2.35 million before deducting the placement agent fe
• $25,000 — Offerings, a non-accountable expense of $25,000, up to $35,000 for its fees and expense
• $35,000 — n-accountable expense of $25,000, up to $35,000 for its fees and expenses of legal coun
• $15,950 — fees and expenses of legal counsel and $15,950 for clearing expenses. The Company has
• $1.875 — issuance, and have an exercise price of $1.875 per share. Further, pursuant to the Eng

Filing Documents

• form8-k.htm (8-K) — 53KB
• ex4-1.htm (EX-4.1) — 119KB
• ex4-2.htm (EX-4.2) — 124KB
• ex5-1.htm (EX-5.1) — 14KB
• ex10-1.htm (EX-10.1) — 263KB
• ex99-1.htm (EX-99.1) — 15KB
• ex99-2.htm (EX-99.2) — 15KB
• ex5-1_001.jpg (GRAPHIC) — 2KB
• 0001493152-24-022560.txt ( ) — 904KB
• mbot-20240603.xsd (EX-101.SCH) — 3KB
• mbot-20240603_lab.xml (EX-101.LAB) — 33KB
• mbot-20240603_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 4KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. /s/ Harel Gadot Harel Gadot Chairman, President and Chief Executive Officer Date: June 4, 2024 4

View Full Filing

View this 8-K filing on SEC EDGAR